A36.85 is a billable ICD-10 code used to specify a medical diagnosis of diphtheritic cystitis. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Diphtheritic cystitis
- Diphtheria-. a localized infection of mucous membranes or skin caused by toxigenic strains of corynebacterium diphtheriae. it is characterized by the presence of a pseudomembrane at the site of infection. diphtheria toxin, produced by c. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.
- Diphtheria Antitoxin-. an antitoxin produced against the toxin of corynebacterium diphtheriae that is used for the treatment of diphtheria.
- Diphtheria Toxin-. an adp-ribosylating polypeptide produced by corynebacterium diphtheriae that causes the signs and symptoms of diphtheria. it can be broken into two unequal domains: the smaller, catalytic a domain is the lethal moiety and contains mono(adp-ribose) transferases which transfers adp ribose to peptide elongation factor 2 thereby inhibiting protein synthesis; and the larger b domain that is needed for entry into cells.
- Diphtheria Toxoid-. the formaldehyde-inactivated toxin of corynebacterium diphtheriae. it is generally used in mixtures with tetanus toxoid and pertussis vaccine; (dtp); or with tetanus toxoid alone (dt for pediatric use and td, which contains 5- to 10-fold less diphtheria toxoid, for other use). diphtheria toxoid is used for the prevention of diphtheria; diphtheria antitoxin is for treatment.
- Diphtheria-Tetanus Vaccine-. a combined vaccine used to prevent infection with diphtheria and tetanus toxoid. this is used in place of dtp vaccine (diphtheria-tetanus-pertussis vaccine) when pertussis vaccine is contraindicated.
- Diphtheria-Tetanus-acellular Pertussis Vaccines-. combined vaccines consisting of diphtheria toxoid; tetanus toxoid; and an acellular form of pertussis vaccine. at least five different purified antigens of b. pertussis have been used in various combinations in these vaccines.
- Diphtheria-Tetanus-Pertussis Vaccine-. a vaccine consisting of diphtheria toxoid; tetanus toxoid; and whole-cell pertussis vaccine. the vaccine protects against diphtheria, tetanus, and whooping cough.
- Fowlpox-. a poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts.
- Heparin-binding EGF-like Growth Factor-. an egf family member that is expressed in a variety of hematopoietic, endothelial, vascular smooth muscle, and epithelial cells. it is synthesized as a transmembrane protein which is cleaved by proteases to produce the secreted form of the protein which has specificity for the egf receptor and the erbb-4 receptor. the membrane-bound form of the protein has been identified as the receptor which binds to and allows diphtheria toxin to enter cells.
- Anterior Nasal Diphtheria-. infection of the anterior nasal structures by corynebacterium diphtheriae.
- Corynebacterium diphtheriae bv. belfanti|CORYNEBACTERIUM DIPHTHERIAE VAR. BELFANTI-. a biovar of corynebacterium diphtheriae distinguished by its morphogenic and biochemical properties. biovar belfanti is positive for fermentation of glucose and maltose. this biovar is one of the two main disease-causing biovars.
- Corynebacterium diphtheriae bv. gravis|CORYNEBACTERIUM DIPHTHERIAE TYPE GRAVIS-. a biovar of corynebacterium diphtheriae distinguished by its morphogenic and biochemical properties. biovar gravis is nitrate positive and positive for fermentation of glucose, maltose, and starch. this biovar is one of the two main disease-causing biovars.
- Corynebacterium diphtheriae bv. intermedius|CORYNEBACTERIUM DIPHTHERIAE TYPE INTERMEDIUS-. a biovar of corynebacterium diphtheriae. biovar intermedius is nitrate positive and positive for fermentation of glucose and maltose.
- Corynebacterium diphtheriae bv. mitis|CORYNEBACTERIUM DIPHTHERIAE TYPE MITIS-. a biovar of corynebacterium diphtheriae. biovar mitis is nitrate positive and positive for fermentation of glucose and maltose.
- Corynebacterium diphtheriae Toxoid Antibody Measurement|CDITDAB|Corynebacterium diphtheriae Toxoid Ab|Corynebacterium diphtheriae Toxoid Ab-. the determination of the amount of corynebacterium diphtheriae toxoid antibody present in a sample.
- Corynebacterium diphtheriae Toxoid|CORYNEBACTERIUM DIPHTHERIAE TOXOID-. the purified and detoxified form of the corynebacterium diphtheriae toxin. toxicity of this toxin is suppressed or inactivated either by heat or with formaldehyde.
- Corynebacterium diphtheriae|CORYNEBACTERIUM DIPHTHERIAE|CORYNEBACTERIUM DIPHTHERIAE-. a species of aerobic or facultatively anaerobic, gram-positive, coryneform, pleomorphic bacilli assigned to the phylum actinobacteria. this species is nonmotile, non-spore forming, catalase positive, non-lipophilic, produces diphtheria toxin which inhibits elongation factor 2 (ef-2) thus preventing protein synthesis, forms polar granules, and is cultured in loeffler's serum in a low iron environment or on tellurite agar. c diphtheriae is commensal in the skin and nasopharynx, but toxin producing strains are pathogenic to humans causing diphtheria; both an antitoxin and vaccine are available for disease prevention.
- Cutaneous Diphtheria-. a usually mild form of diphtheria characterized by infection of the skin by corynebacterium diphtheria and the resulting formation of a chronic, shallow ulcer that is sometimes bordered or followed by a bulla.
- Denileukin Diftitox|DAB(389)-Interleukin-2|DAB(389)IL-2|DAB389 Interleukin-2|DAB389 Interleukin-2 Immunotoxin|DAB389IL-2|DAB389IL2|DENILEUKIN DIFTITOX|Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777|E7777|Interleukin-2 Fusion Protein|Interleukin-2 Fusion Toxin|LY335348|Ontak|Ontak|denileukin diftitox-. a cytotoxic recombinant fusion protein consisting of the human cytokine interleukin-2 (il-2) fused to diphtheria toxin fragments a and b, containing both the catalytic and translocation domains, with potential antineoplastic activity. upon administration, the il-2 moiety of denileukin difitox targets and binds to il-2 receptors. after internalization by il-2 receptor-expressing cells via endocytosis, denileukin difitox is proteolytically cleaved. this releases the catalytic domain of the toxin moiety, which catalyzes the transfer of the adp-ribose moiety of nad to a diphthamide residue of elongation factor 2 (ef-2). this covalent modification inactivates ef-2 and disrupts polypeptide chain elongation, resulting in an inhibition of translation and cell death.
- Diphtheria-. a gram-positive bacterial infection caused by corynebacterium diphtheriae. it usually involves the oral cavity, pharynx, and nasal cavity. patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. the diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.
- Diphtheria IgG Antibody Measurement|Corynebacterium diphtheriae IgG Antibody|DPTIGGAB|Diphtheria IgG Antibody|Diphtheria IgG Antibody-. the determination of the amount of the diphtheria igg antibodies in a sample.
- Diphtheria Toxin|DIPHTHERIA TOXIN (CORYNEPHAGE BETA)-. an exotoxin protein encoded by a bacteriophage that infects corynebacterium diphtheriae (c. diphtheriae) and is the causative agent for the pathology associated with diphtheria. c. diphtheriae secretes a single chain protein toxin that is quickly cleaved into two fragments (the a and b subunits) that are linked by disulfide bridges. the b subunit binds to the plasma membrane of a host cell and forms a pore that allows the catalytic a subunit to be internalized. once in the cytoplasm, the catalytic domain of the toxin moiety dissociates from the b subunit and catalyzes the transfer of the adp-ribose moiety of nad to a diphthamide residue of elongation factor 2 (ef-2). this covalent modification inactivates ef-2 and disrupts polypeptide chain elongation, resulting in an inhibition of protein synthesis and, subsequently, cell death.
- Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed|DT|DT|Diphtheria Toxoid Tetanus Toxoid Vaccine Adsorbed|Diphtheria and Tetanus Toxoids Adsorbed USP (For Pediatric Use)-. a vaccine containing detoxified tetanus toxoid and detoxified diphtheria toxoid adsorbed on aluminum phosphate with active immunizing activity against diphtheria and tetanus. intramuscular injection with this vaccine activates the immune system to develop antibodies against tetanus toxin and diphtheria toxin.
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Adsorbed, Recombinant Hepatitis B/Inactivated Poliovirus Vaccine Combined|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine|Pediarix-. a vaccine consisting of detoxified tetanus toxoid, detoxified diphtheria toxoid, acellular pertussis antigens, inactivated poliovirus (ipv) types 1,2 and 3 and hepatitis b (hbv) surface antigen, with active immunizing activities against diphtheria, tetanus, pertussis, hepatitis b, and poliomyelitis. the acellular pertussis components in this vaccine, produced by bordetella pertussis, are detoxified pertussis toxin (pt), filamentous hemagglutinin (fha) and pertactin (prn). upon intramuscular injection, this vaccine activates the immune system to develop antibodies against tetanus toxin, diphtheria toxin, b. pertussis antigens, polioviruses and hbv. the diphtheria and tetanus toxoids and pertussis antigens (inactivated pt, fha, and pertactin) are adsorbed onto aluminum hydroxide; the hepatitis b antigen is adsorbed onto aluminum phosphate.
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed|Adacel|DTaP|DTaP|Daptacel|Diphtheria Toxoid Tetanus Toxoid Acellular Pertussis Vaccine Adsorbed|Diphtheria Toxoid Tetanus Toxoid Acellular Pertussis Vaccine Adsorbed|Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|Infanrix|Tripedia-. a vaccine containing detoxified tetanus toxoid, detoxified diphtheria toxoid and acellular pertussis antigens, adsorbed on aluminum phosphate, with active immunizing activity against diphtheria, tetanus and pertussis. the acellular pertussis vaccine components, produced by bordetella pertussis, are detoxified pertussis toxin (pt), filamentous hemagglutinin (fha), pertactin (prn) and fimbriae types 2 and 3 (fim). intramuscular injection with this vaccine activates the immune system to develop antibodies against tetanus toxin, diphtheria toxin and b. pertussis antigens.
- Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine|DTP|Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine DTP-. a vaccine containing detoxified tetanus toxoid, detoxified diphtheria toxoid and inactivated pertussis antigens.
- Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliomyelitis-Haemophilus influenzae Type B Vaccine|DTaP(5)-IPV-Hib|DTaP-IPV-Hib|Pediacel-. a vaccine consisting of detoxified diphtheria toxoid (d), detoxified tetanus toxoid (t), acellular pertussis (ap) antigens, inactivated poliovirus (ipv) types 1, 2 and 3, and haemophilus influenzae type b (hib) capsular polysaccharide (polyribosylribitol phosphate; prp) covalently bound to tetanus protein, suspended in water for injection and with active immunizing activity against diphtheria, tetanus, pertussis, poliomyelitis and h. influenzae type b. the five purified pertussis antigens in this vaccine are pertussis toxin (pt), filamentous hemagglutinin (fha), pertactin (prn) and fimbriae types 2 and 3 (fim). upon intramuscular injection of the diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine (dtap-ipv-hib), this vaccine activates the immune system to develop antibodies against diphtheria toxin, tetanus toxin, b. pertussis antigens, polioviruses and hib, thereby providing active immunization against these diseases. the diphtheria and tetanus toxoids and pertussis antigens (inactivated pt, fha, prn and fim) are adsorbed separately onto aluminum phosphate and then combined with ipv and prp.
- DTA-H19 Plasmid|DTA-H19|Diphtheria Toxin A-H19 Plasmid-. a plasmid dna encoding the a chain of the diphtheria toxin (dt-a) driven by the transcriptional regulatory sequences of human h19, with potential antineoplastic activity. because the expression of dt-a is under the control of h19 promotor elements, dt-a is selectively expressed in tumor cells capable of turning on h-19. dt-a catalyzes adp-ribosylation of translation elongation factor 2 (ef-2), resulting in the inhibition of protein synthesis and apoptosis. in addition, dt-a protein released from lysed cells cannot enter and kill neighboring cells because of the absence of the dt-b chain, further enhancing the selective cytotoxicity of this agent. human h19 is a paternally-imprinted, oncofetal gene encoding an rna product; it acts as a riboregulator in gene expression and is found at substantial levels in different human tumor cell types while its expression in normal adult tissue is limited.
- Faucial Diphtheria-. infection of the fauces by corynebacterium diphtheriae.
- HBEGF wt Allele|DT-R|DTR|DTR Gene|DTS|DTSF|Diphtheria Toxin Receptor (Heparin-Binding EGF-Like Growth Factor) Gene|Diphtheria Toxin Receptor (Heparin-Binding Epidermal Growth Factor-Like Growth Factor) Gene|Diphtheria Toxin Receptor Gene|Diphtheria Toxin Sensitivity Gene|HB-EGF|HEGFL|Heparin-Binding EGF-Like Growth Factor wt Allele-. human hbegf wild-type allele is located within 5q23 and is approximately 14 kb in length. this allele, which encodes heparin-binding egf-like growth factor protein, is involved in mitogenesis and cellular proliferation.
- Heparin-Binding EGF-Like Growth Factor|DT-R|DTR|DTR Protein|DTS|Diphtheria Toxin Receptor|Diphtheria Toxin Sensitivity|HB-EGF|HBEGF|HEGFL|Heparin-Binding EGF-. heparin-binding egf-like growth factor (86 aa, ~10 kda) is encoded by the human hbegf gene. this protein is involved in both heart development and mitogenesis.
- Inodiftagene Vixteplasmid|BC 819|BC-819|BC819|Diphtheria-toxin-A-H19|INODIFTAGENE VIXTEPLASMID|dT-A-H19-. a recombinant dna plasmid carrying the gene for diphtheria toxin-a (dt-a) chain under the regulation of the h19 promoter, with potential antineoplastic activity. upon intravesical administration, dt-a chain expression is triggered by the presence of h19 transcription factors that are upregulated in tumor cells. the dt-a chain binds to nicotinamide adenine dinucleotide (nad) and inactivates the adp-ribosylation of elongation factor 2 (ef2), resulting in the inhibition of protein synthesis and cell death leading to tumor cell destruction. inodiftagene vixteplasmid does not carry the gene for the diphtheria toxin-b (dt-b) chain, thereby preventing the transfer of the toxic dt-a chain between cells. h19, a paternally imprinted, oncofetal gene, is highly expressed in embryonic and certain malignant tissues, but minimally expressed in normal, adult tissues.
- Laryngeal Diphtheria-. infection of the larynx by corynebacterium diphtheriae.
- Meningococcal Conjugate Vaccine MCV4|MCV4|Menactra|Meningococcal Conjugate Vaccine MCV-4|Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine|Menveo-. a conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by neisseria meningiditis serogroups a, c, y, and w-135.
- Nasopharyngeal Diphtheria-. infection of the nasopharynx by corynebacterium diphtheriae.
- Pneumococcal 7-Valent Conjugate Vaccine|PCV 7|Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)|Prevnar-. an active immunizing agent used to prevent infection by the bacterium streptococcus pneumoniae. pneumococcal 7-valent conjugate vaccine consists of a solution of saccharides of the capsular antigens of streptococcus serotypes 4, 6b, 9v, 14, 18c, 19f, and 23f individually conjugated to diphtheria crm 197 protein.
- Poly [ADP-Ribose] Polymerase 1 p85|ADP-Ribosyltransferase Diphtheria Toxin-Like 1 p85|ADPRT 1 p85|ARTD1 p85|NAD(+) ADP-Ribosyltransferase 1 p85|PARP p85|PARP1 p85|Poly [ADP-Ribose] Polymerase p85|Poly(ADP Ribose) Polymerase 1 p85|Poly(ADP Ribose) Polymerase p85|Poly[ADP-Ribose] Synthase 1 p85-. poly [adp-ribose] polymerase 1 p85 (800 aa, ~89 kda) is encoded by the human parp1 gene. this protein is released from the full length poly [adp-ribose] polymerase 1 protein by caspase-3 cleavage and is involved in dna repair.
- Poly [ADP-Ribose] Polymerase 1|ADP-Ribosyltransferase|ADP-Ribosyltransferase Diphtheria Toxin-Like 1|ADP-Ribosyltransferase NAD(+)|ADPRT 1|ARTD1|EC 18.104.22.168|NAD(+) ADP-Ribosyltransferase 1|PARP|PARP|PARP-1|PARP-1|PARP1|Poly (ADP Ribose) Polymerase 1|Poly(ADP Ribose) Polymerase|Poly(ADP Ribose) Polymerase 1|Poly(ADP-Ribose) Synthetase|Poly(ADP-Ribosyl)Transferase|Poly[ADP-Ribose] Synthase 1|poly (ADP-ribose) polymerase|poly(ADP-ribose) polymerase-1-. poly [adp-ribose] polymerase 1 (1013aa, ~113 kda) is encoded by the human parp1 gene. this protein is involved in poly adp-ribosylation and in the regulation of various cellular processes such as differentiation, proliferation, tumor transformation, and recovery from dna damage.
- Poly [ADP-Ribose] Polymerase 2|ADP-Ribosyltransferase 2|ADP-Ribosyltransferase Diphtheria Toxin-Like 2|ADP-Ribosyltransferase-Like 2|ADPRT-2|ARTD2|EC 22.214.171.124|NAD(+) ADP-Ribosyltransferase 2|PARP-2|PARP2|Poly (ADP-Ribose) Polymerase 2|Poly (ADP-Ribosyl) Transferase-Like 2|Poly(ADP-Ribose) Synthase 2|Poly[ADP-Ribose] Synthase 2|hPARP-2|pADPRT-2-. poly [adp-ribose] polymerase 2 (583 aa, ~66 kda) is encoded by the human parp2 gene. this protein is involved in the initiation of dna repair.
- Poly [ADP-Ribose] Polymerase Tankyrase-1|ADP-Ribosyltransferase Diphtheria Toxin-Like 5|ARTD5|EC 126.96.36.199|PARP Homolog|Poly [ADP-Ribose] Polymerase 5A|TANK1|TNKS|TNKS-1|TRF1-Interacting Ankyrin-Related ADP-Ribose Polymerase|TRF1-Interacting Ankyrin-Related ADP-Ribose Polymerase 1|Tankyrase|Tankyrase 1|Tankyrase I|Tankyrase-1|Tankyrase-1|Telomeric Poly (ADP-Ribose) Polymerase|Telomeric Poly-(ADP-Ribose)-Polymerase-. poly [adp-ribose] polymerase tankyrase-1 (1327 aa, ~142 kda) is encoded by the human tnks gene. this protein plays a role in poly-adp-ribosylation of protein substrates.
- Poly [ADP-Ribose] Polymerase Tankyrase-2|ADP-Ribosyltransferase Diphtheria Toxin-Like 6|ARTD6|EC 188.8.131.52|Poly [ADP-Ribose] Polymerase 5B|Protein Poly-ADP-Ribosyltransferase Tankyrase-2|TANK2|TNKS-2|TNKS2|TRF1-Interacting Ankyrin-Related ADP-Ribose Polymerase 2|Tankyrase 2|Tankyrase II|Tankyrase-2|Tankyrase-Like Protein|Tankyrase-Related Protein-. poly [adp-ribose] polymerase tankyrase-2 (1166 aa, ~127 kda) is encoded by the human tnks2 gene. this protein is involved in poly-adp-ribosylation of protein substrates and regulates telomere maintenance and protein ubiquitination and degradation.
- Protein Mono-ADP-Ribosyltransferase PARP3|ADP-Ribosyltransferase 3|ADP-Ribosyltransferase Diphtheria Toxin-Like 3|ADP-Ribosyltransferase-Like 3|ADPRT-3|ARTD3|DNA ADP-Ribosyltransferase PARP3|EC 2.4.2.-|IRT1|NAD(+) ADP-Ribosyltransferase 3|NAD+ ADP-Ribosyltransferase 3|PARP-3|PARP3|Poly (ADP-Ribose) Polymerase 3|Poly (ADP-Ribosyl) Transferase-Like 3|Poly [ADP-Ribose] Polymerase 3|Poly [ADP-Ribose] Polymerase 3|Poly(ADP-Ribose) Polymerase 3|Poly(ADP-Ribose) Synthase 3|Poly(ADP-Ribose) Synthetase-3|Poly[ADP-Ribose] Synthase 3|Poly[ADP-Ribose] Synthetase 3|hPARP-3|pADPRT-3-. protein mono-adp-ribosyltransferase parp3 (533 aa, ~60 kda) is encoded by the human parp3 gene. this protein plays a role in dna repair and mono-adp-ribosylation of target proteins.
- Tagraxofusp-erzs|DT(388)-IL3 Fusion Protein|DT388IL3 fusion protein|Diphtheria Toxin(388)-Interleukin-3 Fusion Protein|Elzonris|IL3R-targeting Fusion Protein SL-401|S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol|SL-401|TAGRAXOFUSP|Tagraxofusp|Tagraxofusp ERZS-. a recombinant protein consisting of human interleukin 3 (il3) fused to the first 388 amino acids of diphtheria toxin [dt(388)] (dt388il3) with potential antineoplastic activity. upon intravenous administration of tagraxofusp-erzs, the il3 moiety binds to il3 receptors on cells expressing the receptor. subsequently, the dt(388) toxin moiety, which contains both translocation and catalytic domains, is transported across the cell membrane via endocytosis. within the cytosol, the catalytic domain of the toxin both catalyzes the adp-ribosylation of, and inactivates, translation elongation factor 2 (ef-2), which results in the inhibition of translation during protein synthesis. il3 may be overexpressed by a variety of cancers, including blastic plasmacytoid dendritic cell neoplasm and acute myeloid leukemia (aml).
- TCDD-Inducible Poly [ADP-Ribose] Polymerase|ADP-Ribosyltransferase Diphtheria Toxin-Like 14|ARTD14|EC 184.108.40.206|PARP-7|Poly [ADP-Ribose] Polymerase 7|TIPARP-. tcdd-inducible poly [adp-ribose] polymerase (657 aa, ~76 kda) is encoded by the human tiparp gene. this protein is involved in protein modification.
- Tetanus and Diphtheria Toxoids Adsorbed|DECAVAC|Td|Td|Tetanus and Diphtheria Toxoids Adsorbed for Adult Use-. a sterile, intramuscular suspension of alum (aluminum potassium sulfate)-precipitated toxoids indicated for active immunization for the prevention of tetanus and diphtheria for use in persons 7 years of age or older.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|A36.85||032.84 - Diphtheritic cystitis|
Diphtheria is a serious bacterial infection. You can catch it from a person who has the infection and coughs or sneezes. You can also get infected by coming in contact with an object, such as a toy, that has bacteria on it.
Diphtheria usually affects the nose and throat. Symptoms include:
- Sore throat
- Swollen glands in the neck
Your doctor will diagnose it based on your signs and symptoms and a lab test. Getting treatment for diphtheria quickly is important. If your doctor suspects that you have it, you'll start treatment before the lab tests come back. Treatment is with antibiotics.
The diphtheria, pertussis, and tetanus vaccine can prevent diphtheria, but its protection does not last forever. Children need another dose, or booster, at about age 12. Then, as adults, they should get a booster every 10 years. Diphtheria is very rare in the United States because of the vaccine.
Centers for Disease Control and Prevention
[Learn More in MedlinePlus]
Urinary Tract Infections
The urinary system is the body's drainage system for removing wastes and extra water. It includes two kidneys, two ureters, a bladder, and a urethra. Urinary tract infections (UTIs) are the second most common type of infection in the body.
You may have a UTI if you notice:
- Pain or burning when you urinate
- Fever, tiredness, or shakiness
- An urge to urinate often
- Pressure in your lower belly
- Urine that smells bad or looks cloudy or reddish
- Pain in your back or side below the ribs
People of any age or sex can get UTIs. But about four times as many women get UTIs as men. You're also at higher risk if you have diabetes, need a tube to drain your bladder, or have a spinal cord injury.
If you think you have a UTI it is important to see your doctor. Your doctor can tell if you have a UTI with a urine test. Treatment is with antibiotics.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)